Leishmaniasis transmitted by sandflies is an important vector-borne disease. In Chad, information on outdated, and so this study was designed to update the sandfly fauna. Sandflies were collected in five health districts representing two geoclimatic zones using sticky traps pyrethrum sprays indoor peridomestic habitats between September 2019 December 2020. All specimens identified based species...

Miltefosine was the first oral compound approved for visceral leishmaniasis chemotherapy, and its efficacy against Leishmania donovani has been well documented. Leishmania amazonensis is the second most prevalent species causing cutaneous leishmaniasis and the main etiological agent of diffuse cutaneous leishmaniasis in Brazil. Driven by the necessity of finding alternative therapeutic strategi...

Leishmaniasis is a zoonotic parasitic disease that affects both humans and animals. Canines are considered the main reservoirs of disease, while cats can present as secondary reservoirs, altering epidemiological cycle disease. The work describes first case feline foot hyperkeratosis in Asunción-Paraguay associated with leishmaniasis, determined by cytological diagnosis, favorable response to tr...

INTRODUCTION: In 1950, Waldenstriim reported a series of cases of chronic hepatitis in young women. This generated considerable interest in the disease. Subsequent reports have demonstrated that while it is much more prevalent in the young, it is not confined to them and that cases have been reported from all age groups. Chronic active hepatitis is a syndrome of unknown etiology, characterized ...

BACKGROUND Visceral leishmaniasis is an important opportunistic disease in HIV-positive patients. The information available on the effects of such co-infection in the kidney is limited. We describe a patient with HIV/leishmania coinfection who developed nephrotic syndrome and membranoproliferative glomerulonephritis. As far as we know, only 2 cases of this nephropathy in HIV/leishmania coinfect...

CONTEXT Cutaneous leishmaniasis (CL) is a public health problem in several endemic countries. Recent studies on mouse model and also a few clinical experiments showed that the type of immune response generated at the site of infection and especially balance between regulatory and effector T-cells determines the outcome of the disease toward self-limiting or long-lasting lesions. AIMS The aim ...

Leishmaniasis affects 1.5-2 million new cases in the world annually. Two major complications of cutaneous leishamaniasis include diffuse cutaneous leishamaniasis (DCL ) occurring in the setting of deficient cell mediated immunity, typically with HIV infection, and chronic cutaneous leishamaniasis (CCL ) developing in approximately 4% of L. tropica infections in Iran and Afghanistan which also m...